BBIO•benzinga•
Piper Sandler Maintains Overweight on BridgeBio Pharma, Raises Price Target to $63
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 30, 2025 by benzinga